Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1804 2
1805 1
1811 1
1883 1
1884 1
1914 1
1920 1
1922 2
1941 1
1946 6
1947 4
1949 3
1950 3
1951 6
1952 3
1954 1
1955 3
1956 2
1957 4
1959 2
1960 4
1961 1
1962 1
1963 6
1964 4
1965 5
1966 5
1968 3
1969 8
1970 9
1971 17
1972 7
1973 9
1974 12
1975 4
1976 5
1977 8
1978 14
1979 11
1980 7
1981 10
1982 12
1983 21
1984 22
1985 12
1986 12
1987 12
1988 33
1989 36
1990 23
1991 36
1992 34
1993 34
1994 27
1995 27
1996 39
1997 34
1998 27
1999 28
2000 35
2001 47
2002 40
2003 46
2004 43
2005 40
2006 42
2007 41
2008 42
2009 55
2010 52
2011 59
2012 50
2013 67
2014 70
2015 68
2016 64
2017 67
2018 59
2019 85
2020 108
2021 58
Text availability
Article attribute
Article type
Publication date

Search Results

1,786 results
Results by year
Filters applied: . Clear all
Page 1
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.
Kather JN, Pearson AT, Halama N, Jäger D, Krause J, Loosen SH, Marx A, Boor P, Tacke F, Neumann UP, Grabsch HI, Yoshikawa T, Brenner H, Chang-Claude J, Hoffmeister M, Trautwein C, Luedde T. Kather JN, et al. Among authors: pearson at. Nat Med. 2019 Jul;25(7):1054-1056. doi: 10.1038/s41591-019-0462-y. Epub 2019 Jun 3. Nat Med. 2019. PMID: 31160815 Free PMC article.
Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL. Pinto NR, et al. Among authors: pearson ad. J Clin Oncol. 2015 Sep 20;33(27):3008-17. doi: 10.1200/JCO.2014.59.4648. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304901 Free PMC article. Review.
The challenge of defining "ultra-high-risk" neuroblastoma.
Morgenstern DA, Bagatell R, Cohn SL, Hogarty MD, Maris JM, Moreno L, Park JR, Pearson AD, Schleiermacher G, Valteau-Couanet D, London WB, Irwin MS. Morgenstern DA, et al. Among authors: pearson ad. Pediatr Blood Cancer. 2019 Apr;66(4):e27556. doi: 10.1002/pbc.27556. Epub 2018 Nov 26. Pediatr Blood Cancer. 2019. PMID: 30479064 Review.
The systematic review: an overview.
Aromataris E, Pearson A. Aromataris E, et al. Among authors: pearson a. Am J Nurs. 2014 Mar;114(3):53-8. doi: 10.1097/01.NAJ.0000444496.24228.2c. Am J Nurs. 2014. PMID: 24572533
Dexamethasone as an adjuvant to peripheral nerve block.
Pehora C, Pearson AM, Kaushal A, Crawford MW, Johnston B. Pehora C, et al. Among authors: pearson am. Cochrane Database Syst Rev. 2017 Nov 9;11(11):CD011770. doi: 10.1002/14651858.CD011770.pub2. Cochrane Database Syst Rev. 2017. PMID: 29121400 Free PMC article. Review.
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK, Valteau-Couanet D. Park JR, et al. Among authors: pearson ad. J Clin Oncol. 2017 Aug 1;35(22):2580-2587. doi: 10.1200/JCO.2016.72.0177. Epub 2017 May 4. J Clin Oncol. 2017. PMID: 28471719 Free PMC article. Review.
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.
Herrera-Abreu MT, Palafox M, Asghar U, Rivas MA, Cutts RJ, Garcia-Murillas I, Pearson A, Guzman M, Rodriguez O, Grueso J, Bellet M, Cortés J, Elliott R, Pancholi S, Baselga J, Dowsett M, Martin LA, Turner NC, Serra V. Herrera-Abreu MT, et al. Among authors: pearson a. Cancer Res. 2016 Apr 15;76(8):2301-13. doi: 10.1158/0008-5472.CAN-15-0728. Epub 2016 Mar 28. Cancer Res. 2016. PMID: 27020857 Free PMC article.
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View.
Xavier JB, Young VB, Skufca J, Ginty F, Testerman T, Pearson AT, Macklin P, Mitchell A, Shmulevich I, Xie L, Caporaso JG, Crandall KA, Simone NL, Godoy-Vitorino F, Griffin TJ, Whiteson KL, Gustafson HH, Slade DJ, Schmidt TM, Walther-Antonio MRS, Korem T, Webb-Robertson BM, Styczynski MP, Johnson WE, Jobin C, Ridlon JM, Koh AY, Yu M, Kelly L, Wargo JA. Xavier JB, et al. Among authors: pearson at. Trends Cancer. 2020 Mar;6(3):192-204. doi: 10.1016/j.trecan.2020.01.004. Epub 2020 Feb 7. Trends Cancer. 2020. PMID: 32101723 Free PMC article. Review.
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.
Chopra N, Tovey H, Pearson A, Cutts R, Toms C, Proszek P, Hubank M, Dowsett M, Dodson A, Daley F, Kriplani D, Gevensleben H, Davies HR, Degasperi A, Roylance R, Chan S, Tutt A, Skene A, Evans A, Bliss JM, Nik-Zainal S, Turner NC. Chopra N, et al. Among authors: pearson a. Nat Commun. 2020 May 29;11(1):2662. doi: 10.1038/s41467-020-16142-7. Nat Commun. 2020. PMID: 32471999 Free PMC article. Clinical Trial.
1,786 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page